Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice

BACKGROUND: Vascular stiffening, a risk factor for cardiovascular disease, is accelerated, particularly in women with obesity and type 2 diabetes. Preclinical evidence suggests that dipeptidylpeptidase-4 (DPP-4) inhibitors may have cardiovascular benefits independent of glycemic lowering effects. Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Manrique, Camila, Habibi, Javad, Aroor, Annayya R., Sowers, James R., Jia, Guanghong, Hayden, Melvin R., Garro, Mona, Martinez-Lemus, Luis A., Ramirez-Perez, Francisco I., Klein, Thomas, Meininger, Gerald A., DeMarco, Vincent G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938903/
https://www.ncbi.nlm.nih.gov/pubmed/27391040
http://dx.doi.org/10.1186/s12933-016-0414-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938903/
https://www.ncbi.nlm.nih.gov/pubmed/27391040
http://dx.doi.org/10.1186/s12933-016-0414-5

Ejemplares similares